AGILENT
LIVE

Serial Number

77833273

Owner

AGILENT TECHNOLOGIES, INC.

Attorney

Andrew Roppel

Filing Date

Sep 23, 2009

Add to watchlist:

No watchlists yet
View on USPTO

AGILENT Trademark

Serial Number: 77833273 • Registration: 4085588

AGILENT is a trademark filed by AGILENT TECHNOLOGIES, INC. on September 23, 2009. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 4 (Lubricants & Fuels). The application is currently registered and active.

Owner Contact Info

AGILENT TECHNOLOGIES, INC. (712 trademarks)

SANTA CLARA, CA 95051

Entity Type: 03

Trademark Details

Filing Date

September 23, 2009

Registration Date

January 17, 2012

Published for Opposition

November 1, 2011

Goods & Services

lubricating oil and grease for vacuum pumps

polishing powder

House mark for a full line of reagents for scientific or medical research use; house mark for a full line of chemicals for scientific purposes used in spectroscopy, mass spectrometry, chromatography and electrophoresis and for sample preparation for spectroscopy, mass spectrometry, chromatography and electrophoresis; chemicals used in industry and science, namely, for use in spectroscopy, mass spectrometry, chromatography, or electrophoresis or in sample preparation for spectroscopy, mass spectrometry, chromatography, or electrophoresis including standards all for scientific, clinical and scientific research use; reagents for scientific and research use; aqueous and organic solvents in the nature of chemical preparations for scientific and research use; cleaning detergents for industrial use, namely, for scientific and research use; chemicals for scientific purposes, namely, calibrants for performance verification of scientific instrumentation; ampholytes, namely, chemical products in the nature of preparations for scientific use for use in the separation and purification of any charge carrying molecule such as proteins and other molecules of biological origin as well as synthetic chemicals, these products being carrier ampholytes designed for use in isoelectric focusing, isotachophoresis and iso exchange chromatograph; chemicals, namely, buffer and standard solutions used in analytical chemistry; catalysts for chemical and biochemical processes; reagents, namely, matrices for scientific or medical research use; electrophoresis gels other than for medical or veterinary purposes; chromatography chemicals, namely, silica gel, polymers and solvents all for use in chromatography; purifying filtering and absorbing chemicals for use in industry, including for scientific and research use; solid phase extraction chemicals for use in the chromatography industry; chemical and biological standards, namely, chemical reagents for scientific and research use used in DNA, RNA and protein analysis; reagents for research purposes for scientific or medical research use; DNA labeling reagents for research purposes; DNA hybridization buffers, namely, reagents for research purposes for use in DNA hybridization; DNA cloning vectors, namely, reagents for scientific and research use; genomic cloning vectors, namely, reagents for scientific and research use; eukaryotic expression vectors, namely, reagents for scientific and research use; prokaryotic expression vectors, namely, reagents for scientific and research use; yeast shuttle vectors, namely, reagents for scientific and research use; competent cells, namely, reagents for scientific and research use; host cells, namely, reagents for scientific and research use; scientific and research laboratory reagents for molecular biological use, namely, packaging extracts used for inserting DNA into phages; polymerase chain reaction or PCR related products, namely, reagents for scientific and research use; nucleic acid markers, namely, reagents for scientific and research use; reagents used as protein standards for scientific, medical and research use; reagents used as synthetic peptide and protein digest standards for scientific and research use; reagents, namely, DNA primers and DNA vectors for scientific and research use; modifying enzymes not for medical use, namely, polymerase, nucleases, reverse transcriptases, ligases, kinases, phosphatases, glycosylases and transferases for scientific and research use; restriction enzymes for scientific and research use; media supplements, namely, reagents for scientific and research use; [ lymphokines, namely, reagents for scientific and research use; ] cytokines, namely, reagents for scientific and research use; kits for molecular biological research, namely, DNA cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, genomic cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transfection kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, purification kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, polymerase chain reaction or PCR related cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, ligase chain reaction or LCR kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, library construction kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, labeling kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, sequencing kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, mutagenesis kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for scientific and research use, namely, protein analysis kits said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transcription kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, translation kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; and kits for molecular biological research, namely, in situ hybridization kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jun 24, 2022 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jun 24, 2022 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jun 24, 2022 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 24, 2022 APRE
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 23, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 23, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 23, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 23, 2022 COAR
TEAS SECTION 8 & 9 RECEIVED
Jan 18, 2022 E89R
NOTICE OF SUIT
Jan 28, 2021 NOSU
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 17, 2021 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 25, 2020 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Aug 25, 2020 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 25, 2020 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 8, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 8, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 8, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 8, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 8, 2020 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 4, 2017 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 4, 2017 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 4, 2017 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 16, 2017 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 17, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 17, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2011 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 23, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 7, 2011 GNRN
NON-FINAL ACTION E-MAILED
Mar 7, 2011 GNRT
NON-FINAL ACTION WRITTEN
Mar 7, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2011 CRFA
ASSIGNED TO LIE
Jan 28, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 26, 2011 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 16, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 16, 2010 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 26, 2010 GNRN
NON-FINAL ACTION E-MAILED
Jul 26, 2010 GNRT
NON-FINAL ACTION WRITTEN
Jul 26, 2010 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 29, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 28, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 28, 2009 GNRN
NON-FINAL ACTION E-MAILED
Dec 28, 2009 GNRT
NON-FINAL ACTION WRITTEN
Dec 28, 2009 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2009 NWOS
NEW APPLICATION ENTERED
Sep 26, 2009 NWAP